AM
Amarantus BioScience Holdings, Inc.
AMBS · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $36.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.39x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 83.17%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
FCF margin 4,719.67%
Net margin 4,995.23%
Quality
14 /100
Poor ROIC 4.85%
Asset turnover 0.01x
ROA 46.65%
Debt
70 /100
Low Current ratio 0.00x
Net debt/EBITDA -4.22x
Debt/Equity N/A
Stability
19 /100
Unstable Beta -4.74x
Profitable years 0
EPS volatility 679.53%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre AMBS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Wesley Commissiong
Employees
12
Headquarters
New York City